SightMD NJ Surgeon performs first implantation of this revolutionary intraocular lens in New Jersey
Retrieved on:
Tuesday, April 25, 2023
Retina, Cornea, Surgeon, Dioptre, Cataract, Eye, Hope, Astigmatism, MD, Patient, Emmetropia, Intraocular lens, FDA, GLARE, Dentistry, Telescopic sight, Aphera, IOL
HAUPPAUGE, N.Y., April 25, 2023 /PRNewswire-PRWeb/ -- A dramatically New design IntraOcular Lens called the Apthera IC-8 was approved by the FDA and released in Jan of 2023 and we are excited to announce that the first implantation of this revolutionary intraocular lens in New Jersey was performed by SightMD Ophthalmic Surgeon Omar F. Almallah, MD last week.
Key Points:
- The IC-8 Apthera Intraocular Lens (IOL) is an artificial lens implanted in the eye of adult patients.
- The lens is intended to provide vision correction after the eye's natural lens is removed because it has become cloudy (cataract).
- The IC-8 Apthera IOL is the first small aperture lens that delivers extended depth of focus through its distinctive wavefront-filtering design.
- The IC-8 Apthera lens is an extended depth of focus intraocular lens.